Clinical Trial Update: Pacemaker Holter Assessment of the Effect of BMS-914392 on Atrial Fibrillation Burden [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the effect of BMS-914392 on atrial fibrillation burden using pacemaker Holter assessment; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• BMS-914392 (BMS-914392)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED